🇵🇭 QSC Peptides Philippines  ·  Order from QSC →

Buy Tirzepatide in the Philippines

Asia Warehouse CAS 2023788-19-2  ·  Dual GLP-1+GIP Agonist  ·  5–8 days  ·  >=99% purity

Tirzepatide is the first approved dual GLP-1+GIP receptor agonist. SURMOUNT-1 demonstrated 20.9% mean weight reduction over 72 weeks with 15 mg weekly. QSC Asia warehouse to Philippines in 5–8 business days.

Tirzepatide (CAS 2023788-19-2, MW 4813.5 Da): Tirzepatide (CAS 2023788-19-2, MW ≈4813.5 Da) is the first approved dual GLP-1 receptor and GIP receptor agonist. SURMOUNT-1 (NCT04184622) demonstrated 20.9% mean body weight reduction at 72 weeks with 15 mg weekly dosing, the highest published reduction in Phase 3 at the time of reporting. QSC (Qingdao Sigma Chemical) supplies research-grade tirzepatide at ≥99% HPLC purity with Janoshik-verified COA. Clinical trial references: NCT04184622 (SURMOUNT-1); NCT04657003 (SURMOUNT-2). Order at qscpeptide.com.

Buy Tirzepatide — Asia Warehouse to Philippines

₱3,534 / USD 62 · 5–8 business days nationwide. >=99% HPLC, Janoshik COA. Bitcoin and USDT accepted.

Buy Tirzepatide at QSC →

Philippines Shipping Details

DestinationDelivery Time
Metro Manila (NCR)5–8 business days
Luzon (outside NCR)6–10 business days
Visayas (Cebu, Iloilo, Bacolod)7–11 business days
Mindanao (Davao, Cagayan de Oro)7–11 business days
Tracking numberAll orders
Shipping costFree
Purity>=99% HPLC
COAJanoshik (independent)
PaymentBitcoin / USDT
PricingPHP and USD listed

Tirzepatide — Variants and PHP Pricing

QSC-TIRZEPATIDE-5MG
Tirzepatide 5mg
₱3,534
USD 62 · Dual GLP-1+GIP Agonist
Buy at QSC →
QSC-TIRZEPATIDE-10MG
Tirzepatide 10mg
₱5,700
USD 100 · Dual GLP-1+GIP Agonist
Buy at QSC →
QSC-TIRZEPATIDE-15MG
Tirzepatide 15mg
₱7,866
USD 138 · Dual GLP-1+GIP Agonist
Buy at QSC →

Mechanism of Action

Tirzepatide simultaneously activates GLP-1R and GIPR. Co-activation of the GIP receptor potentiates glucose-dependent insulin secretion, improves peripheral insulin sensitivity in adipose tissue and reduces hepatic gluconeogenesis.

Tirzepatide — Research Data

SURMOUNT-1 (NCT04184622): Tirzepatide 15 mg produced 20.9% mean weight reduction at 72 weeks. SURMOUNT-2 in T2DM: 13.4%. First GLP-1 compound to exceed 20% in a published Phase 3 trial.

Available Nationwide

QSC ships Tirzepatide from the Asia regional warehouse to all Philippine regions: Metro Manila (NCR), Luzon (Baguio, Angeles, Batangas, Laguna), Visayas (Cebu, Iloilo, Bacolod, Dumaguete) and Mindanao (Davao, Cagayan de Oro, General Santos, Zamboanga). Research institutions nationwide — UP Manila, Ateneo, De La Salle, UST, UP Cebu — all within the delivery window. QSC (Qingdao Sigma Chemical Co., Ltd.) is a direct manufacturer since 2016. Purity >=99% HPLC, Janoshik COA verifiable at janoshik.com. PHP and USD pricing shown. Payment: Bitcoin (BTC) and USDT/USDC only.

Shipping InfoAll CompoundsSemaglutideTirzepatideCagrilintideRetatrutide

QSC Network

For Research Use Only. All compounds are exclusively for laboratory research. Not intended for human consumption. Shipped from QSC Asia regional warehouse.